Atlas Trials

Bioequivalence And Lack Of Food Effects Of 300mg Lamotrigine XR

Clinical trial NCT00412191 · COMPLETED

Trial details

NCT number
NCT00412191
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Epilepsy
Start date
2007-02-06
Primary completion
2007-04-27
Enrollment
180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.